Bertil Olofsson
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Renin-Angiotensin System Studies
-
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
Papers in
-
- Heart Failure Treatment and Management 19
- Blood Pressure and Hypertension Studies 9
-
- Analytical Methods in Pharmaceuticals 7
- Co-authors
- Salim Yusuf (26 shared papers)John J.V. McMurray (26 shared papers)Karl Swedberg (22 shared papers)Eric L. Michelson (22 shared papers)Jan Östergren (17 shared papers)Marc A. Pfeffer (20 shared papers)Christopher B. Granger (19 shared papers)Peter Held (7 shared papers)
- Journals
- The Lancet (7 papers)Journal of the American College of Cardiology (6 papers)European Journal of Heart Failure (6 papers)Blood Pressure (4 papers)The Journal of Clinical Pharmacology (4 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Bertil Olofsson
57 papers receiving 11.2k citations
Bertil Olofsson's Hit Papers
Peers
Comparison fields: 5 of 121
- Cardiology and Cardiovascular Medicine 8.6k
- Endocrinology, Diabetes and Metabolism 2.3k
- Family Practice 227
- Geriatrics and Gerontology 165
- Nephrology 276
Countries citing papers authored by Bertil Olofsson
This map shows the geographic impact of Bertil Olofsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Olofsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Olofsson more than expected).
Fields of papers citing papers by Bertil Olofsson
This network shows the impact of papers produced by Bertil Olofsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Olofsson. The network helps show where Bertil Olofsson may publish in the future.
Co-authors
The 25 scholars most cited alongside Bertil Olofsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Hit paper breakdown → | 2003 | 2056 |
| 2 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Hit paper breakdown → | 2003 | 1796 |
| 3 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Hit paper breakdown → | 2003 | 1340 |
| 4 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Hit paper breakdown → | 2003 | 1121 |
| 5 | The Study on Cognition and Prognosis in the Elderly (SCOPE) Hit paper breakdown → | 2003 | 1033 |
| 6 | CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL Hit paper breakdown → | 2003 | 795 |
| 7 | 2005 | 344 | |
| 8 | CHARM INVESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT-VENTRICULAR EJECTION FRACTION: THE CHARM-PRESERVED TRIAL | 2003 | 329 |
| 9 | 2004 | 283 | |
| 10 | 2006 | 251 | |
| 11 | 1999 | 228 | |
| 12 | 2009 | 227 | |
| 13 | 2006 | 194 | |
| 14 | 2006 | 182 | |
| 15 | 2005 | 159 | |
| 16 | 2004 | 141 | |
| 17 | 2007 | 131 | |
| 18 | 2003 | 111 | |
| 19 | 2009 | 109 | |
| 20 | 2004 | 73 |
About Bertil Olofsson
Bertil Olofsson is a scholar working on Cardiology and Cardiovascular Medicine, Analytical Chemistry, Pharmacology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 11.8k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (19 papers), Blood Pressure and Hypertension Studies (9 papers), Analytical Methods in Pharmaceuticals (7 papers), Pharmaceutical studies and practices (5 papers), Pharmacology and Obesity Treatment (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Potassium and Related Disorders (3 papers) and Dementia and Cognitive Impairment Research (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.6k citations), Endocrinology, Diabetes and Metabolism (2.3k citations), Family Practice (227 citations), Geriatrics and Gerontology (165 citations) and Nephrology (276 citations). Bertil Olofsson has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Salim Yusuf, John J.V. McMurray, Karl Swedberg, Eric L. Michelson, Jan Östergren, Marc A. Pfeffer, Christopher B. Granger, Peter Held, Dag Elmfeldt and Peter Trenkwalder. Their work appears in journals such as The Lancet, Journal of the American College of Cardiology, European Journal of Heart Failure, Blood Pressure and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.